GlaxoSmithKline Budget Analyst Salaries in Boulder | Comparably
"GlaxoSmithKline discovers, develops and manufactures pharmaceuticals, vaccines and consumer healthcare products." read more
EMPLOYEE
PARTICIPANTS
38
TOTAL
RATINGS
380

GlaxoSmithKline Budget Analyst Salaries in Boulder

The average GlaxoSmithKline Budget Analyst in Boulder earns an estimated $82,040 annually. GlaxoSmithKline's Budget Analyst compensation is $14,115 more than the US average for a Budget Analyst.

In Boulder, The Finance Department at GlaxoSmithKline earns $6,369 more on average than the Operations Department.

Last updated 2 years ago.

$35k
$45k
$53k
$62k
$96k
$135k
$158k
$82,040
Average Compensation
$82,040
avg. base

Budget Analyst Salaries at GlaxoSmithKline

In Boulder, Budget Analysts earn $301 more than Business Analysts, and $11,915 less than Senior Accountants.

Accounting Manager
$95k*
Senior Accountant
$94k*
Business Analyst
$82k*
Financial Analyst
$76k*
Accountant
$69k*
* estimated salary

Compensation at GlaxoSmithKline by Department

In Boulder, The Finance Department averages $6,369 more than the Operations Department, and $13,811 less than the Sales Department

Sales
$91,628 Avg. total comp.
+$14k
Finance
$77,817 Avg. total comp.
Operations
$71,448 Avg. total comp.
-$6k

Budget Analyst Compensation by Gender (All Companies)

The average female Budget Analyst at companies similar size to GlaxoSmithKline reported making $98,833, while the average male Budget Analyst at similar sized companies reported making $76,324.

Budget Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Budget Analyst at companies similar size to GlaxoSmithKline reported making $101,500, while the average African American/Black Budget Analyst at similar sized companies reported making $70,000.

How Budget Analysts at GlaxoSmithKline Rate Their Compensation

The majority of Budget Analysts at GlaxoSmithKline believe they're compensated fairly. 100% of Budget Analysts at GlaxoSmithKline say they receive annual bonuses, and the majority (54%) are satisfied with their benefits. See more compensation ratings at GlaxoSmithKline

×
Rate your company